European regulatory agency says Novavax Covid-19 vaccine must carry heart-side effect warning
The following is an excerpt from Reuters. The European Medicines Agency (EMA) is recommending Novavax’s Covid-19 vaccine carry a warning of the possibility of two types of heart inflammation, an added burden for a shot that has so far failed to win wide uptake. The heart conditions – myocarditis and pericarditis – should be listed […]
Read the full post at Sharyl Attkisson .
Subscribe
Login
0 Comments